Release of Liposomal Contents by Cell-Secreted Matrix Metalloproteinase-9
- 24 June 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 20 (7) , 1332-1339
Abstract
Liposomes have been widely used as a drug delivery vehicle, and currently, more than 10 liposomal formulations are approved by the Food and Drug Administration for clinical use. However, upon targeting, the release of the liposome-encapsulated contents is usually slow. We have recently demonstrated that contents from appropriately formulated liposomes can be rapidly released by the cancer-associated enzyme matrix metalloproteinase-9 (MMP-9). Herein, we report our detailed studies to optimize the liposomal formulations. By properly selecting the lipopeptide, the major lipid component, and their relative amounts, we demonstrate that the contents are rapidly released in the presence of cancer-associated levels of recombinant human MMP-9. We observed that the degree of lipid mismatch between the lipopepides and the major lipid component profoundly affects the release profiles from the liposomes. By utilizing the optimized liposomal formulations, we also demonstrate that cancer cells (HT-29) which secrete low levels of MMP-9 failed to release a significant amount of the liposomal contents. Metastatic cancer cells (MCF7) secreting high levels of the enzyme rapidly release the encapsulated contents from the liposomes.Keywords
This publication has 42 references indexed in Scilit:
- Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptideInternational Journal of Pharmaceutics, 2009
- Tumor-Specific Anti-Nucleosome Antibody Improves Therapeutic Efficacy of Doxorubicin-Loaded Long-Circulating Liposomes against Primary and Metastatic Tumor in MiceMolecular Pharmaceutics, 2008
- The hemopexin domain of MMP‐9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude miceInternational Journal of Cancer, 2008
- Progress in matrix metalloproteinase researchMolecular Aspects of Medicine, 2008
- Mechanistic Studies of the Triggered Release of Liposomal Contents by Matrix Metalloproteinase-9Journal of the American Chemical Society, 2008
- Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactionsProceedings of the National Academy of Sciences, 2008
- Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold NanoshellsJournal of the American Chemical Society, 2008
- Targeted pharmaceutical nanocarriers for cancer therapy and imagingThe AAPS Journal, 2007
- Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor EffectClinical Cancer Research, 2007
- “SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical NanocarriersBioconjugate Chemistry, 2006